Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1997 3
1998 2
1999 1
2000 2
2001 2
2002 4
2003 7
2004 4
2005 9
2006 7
2007 9
2008 5
2009 7
2010 2
2011 9
2012 10
2013 11
2014 7
2015 5
2016 1
2017 2
2018 4
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22826001

114 results
Results by year
Filters applied: . Clear all
Page 1
From outlier to trendsetter.
Bhaumik S, Biswas T. Bhaumik S, et al. CMAJ. 2012 Sep 4;184(12):E635-6. doi: 10.1503/cmaj.109-4246. Epub 2012 Jul 23. CMAJ. 2012. PMID: 22826001 Free PMC article. No abstract available.
Indian health groups welcome country's first compulsory licence.
Mudur G. Mudur G. BMJ. 2012 Mar 16;344:e2132. doi: 10.1136/bmj.e2132. BMJ. 2012. PMID: 22427312 No abstract available.
Bayer challenges India's first compulsory licence for generic version of cancer drug.
Arie S. Arie S. BMJ. 2012 Sep 6;345:e6015. doi: 10.1136/bmj.e6015. BMJ. 2012. PMID: 22956561 No abstract available.
The new patent regime and disease priorities in India.
Gupta I, Guin P, Trivedi M. Gupta I, et al. Glob Public Health. 2013;8(1):37-54. doi: 10.1080/17441692.2012.704060. Epub 2012 Jul 30. Glob Public Health. 2013. PMID: 22845021
Indian biogenerics industry emerges.
Jayaraman KS. Jayaraman KS. Nat Biotechnol. 2003 Oct;21(10):1115-6. doi: 10.1038/nbt882. Nat Biotechnol. 2003. PMID: 14520378 No abstract available.
A generic problem.
Hanauer SB. Hanauer SB. Nat Clin Pract Gastroenterol Hepatol. 2006 Dec;3(12):649. doi: 10.1038/ncpgasthep0659. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 17130869 No abstract available.
Generics battle brand names over mortality of drug patents.
Betz R. Betz R. J Healthc Resour Manag. 1995 Jul;13(7):35-7. J Healthc Resour Manag. 1995. PMID: 10144008 No abstract available.
Delaying generic competition--corporate payoffs and the future of Plavix.
Shuchman M. Shuchman M. N Engl J Med. 2006 Sep 28;355(13):1297-300. doi: 10.1056/NEJMp068193. N Engl J Med. 2006. PMID: 17005945 No abstract available.
A trade agreement's impact on access to generic drugs.
Shaffer ER, Brenner JE. Shaffer ER, et al. Health Aff (Millwood). 2009 Sep-Oct;28(5):w957-68. doi: 10.1377/hlthaff.28.5.w957. Epub 2009 Aug 25. Health Aff (Millwood). 2009. PMID: 19706626
The ongoing regulation of generic drugs.
Frank RG. Frank RG. N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193. N Engl J Med. 2007. PMID: 18003956 No abstract available.
114 results
Jump to page
Feedback